Changes in Plasma and Extracellular Fluid Volume during Long-term Treatment with α-methyldopa in 11 Thiazide-treated Patients with Essential Hypertension

2009 ◽  
Vol 198 (1-6) ◽  
pp. 45-48 ◽  
Author(s):  
A. Leth ◽  
H. Ibsen
Keyword(s):  
Essential Hypertension ◽  
Extracellular Fluid ◽  
Term Treatment ◽  
Fluid Volume ◽  
Extracellular Fluid Volume ◽  
Long Term Treatment

Plasma Volume and Extracellular Fluid Volume during Long-Term Treatment with Propranolol in Essential Hypertension

1972 ◽  
Vol 43 (2) ◽  
pp. 165-170 ◽  
Author(s):  
P. Sederberg-Olsen ◽  
H. Ibsen
Keyword(s):  
Essential Hypertension ◽  
Plasma Volume ◽  
Extracellular Fluid ◽  
Term Treatment ◽  
Fluid Volume ◽  
Extracellular Fluid Volume ◽  
Long Term Treatment ◽  
Significant Change

1. In ten patients with essential hypertension treated with propranolol (320 mg daily for 4 months) plasma volume and extracellular fluid volume were determined. 2. A significant increase in extracellular fluid volume (ECFV) was found, but there was no significant change in plasma volume. 3. The genesis of the increase found in ECFV is briefly discussed.

Efficacy and Tolerability of Muzolimine in the Long-Term Treatment of Essential Hypertension

1987 ◽  
pp. 317-319 ◽  
Author(s):  
M. Carnovali ◽  
C. Borgnino ◽  
E. Crespi ◽  
M. Panozzo ◽  
A. Missaglia ◽  
...  
Keyword(s):  
Essential Hypertension ◽  
Term Treatment ◽  
Long Term Treatment

Complications in long term treatment of essential hypertension

2009 ◽  
Vol 209 (S646) ◽  
pp. 123-126
Author(s):  
H. Løken ◽  
H. & Hebnes ◽  
K. Diakonissesykehus
Keyword(s):  
Essential Hypertension ◽  
Term Treatment ◽  
Long Term Treatment

scholarly journals Long-term treatment of essential hypertension using nadolol and hydrochlorothiazide combined.

1979 ◽  
Vol 7 (S2) ◽  
pp. 199S-203S ◽  
Author(s):  
MM El-Mehairy ◽  
A Shaker ◽  
M Ramadan ◽  
S Hamza ◽  
SS Tadros
Keyword(s):  
Essential Hypertension ◽  
Term Treatment ◽  
Long Term Treatment

Haemodynamic and clinical effects of long-term treatment of essential hypertension with captopril

1983 ◽  
Vol 4 (7) ◽  
pp. 496-501 ◽  
Author(s):  
B. RICCIARDELLI ◽  
M. VOLPE ◽  
B. TRIMARCO ◽  
N. DE LUCA ◽  
A. CUOCOLO ◽  
...  
Keyword(s):  
Essential Hypertension ◽  
Term Treatment ◽  
Clinical Effects ◽  
Long Term Treatment

Increase of Total Body Potassium and Decrease of Exchangeable Sodium after Long-Term Treatment with a β-Receptor-Blocking Agent (Prindolol) in Essential Hypertension

1976 ◽  
Vol 51 (s3) ◽  
pp. 551s-554s
Author(s):  
H. M. Brecht ◽  
E. Werner ◽  
W. Schoeppe
Keyword(s):  
Essential Hypertension ◽  
Plasma Renin Activity ◽  
Plasma Renin ◽  
Term Treatment ◽  
Renin Activity ◽  
Exchangeable Sodium ◽  
Total Body Potassium ◽  
Long Term Treatment ◽  
Total Body

1. The effect of long-term treatment with prindolol on blood pressure, total body potassium (Kt), exchangeable sodium (Nae) and plasma renin activity was investigated in twelve patients with essential hypertension. 2. Systolic and diastolic pressures were significantly reduced from 164/112 to 127/90 mmHg under basal conditions. 3. Before treatment Na. in patients with essential hypertension was significantly higher than in normotensive individuals. After an average of 16 weeks on prindolol Nae in patients with essential hypertension was significantly decreased, despite an average increase in body weight of 2 kg in the patients. 4. In contrast to the decrease in Nae, Kt was found to be significantly increased after long-term treatment with prindolol. Kt values of patients before and after prindolol, however, did not differ significantly from the corresponding sex- and age-dependent normal values. 5. Plasma renin activity was slightly diminished under basal and orthostatic conditions; the stimulatory effect of orthostasis was not abolished but reduced by prindolol. 6. It is suggested that the changes in sodium balance contribute to the anti-hypertensive effect of prindolol in patients with essential hypertension.

Sign in / Sign up

Export Citation Format

Share Document